Active Ingredient (In Each Spray)
Azelastine hydrochloride 205.5 mcg (equivalent to 187.6 mcg azelastine)
The following Structured Product Label (SPL) was submitted to the FDA by Walgreens for the product Azelastine Hydrochloride (NDC 0363-0653). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each spray), purpose, uses, warnings, ask a doctor before use if you, when using this product, stop use and ask a doctor if, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Azelastine hydrochloride 205.5 mcg (equivalent to 187.6 mcg azelastine)
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Only for use in the nose. Do not spray in eyes or mouth.
| adults and children 12 years and older | This product may be used either once or twice a day:
|
| children 6 years to 11 years |
|
| children under 6 years | do not use |
benzalkonium chloride, edetate disodium dihydrate, hypromellose, purified water, sodium citrate (dihydrate), sorbitol, sucralose
call toll free 1-800-706-5575, weekdays, 8:30am – 5:00pm Eastern Standard Time
Bottle LABEL - PRINCIPAL DISPLAY PANEL
NDC 0363-0653-01
Azelastine Hydrpchloride Nasal Spray (205.5 mcg per spray)
ANTIHISTAMINE NASAL SPRAY
60 Metered Sprays
Bottle LABEL - PRINCIPAL DISPLAY PANEL
NDC 0363-0653-02
Azelastine Hydrochloride Nasal Spray (205.5 mcg per spray)
ANTIHISTAMINE NASAL SPRAY
120 Metered Sprays
CARTON LABEL - PRINCIPAL DISPLAY PANEL
NDC 0363-0653-03
Azelastine Hydrochloride Nasal Spray (205.5 mcg per spray)
60 Metered Sprays
ANTIHISTAMINE NASAL SPRAY
24 Hour Relief of:
CARTON LABEL - PRINCIPAL DISPLAY PANEL
NDC 0363-0653-04
Azelastine Hydrochloride Nasal Spray (205.5 mcg per spray)
120 Metered Sprays
ANTIHISTAMINE NASAL SPRAY
24 Hour Relief of:
* Please review the disclaimer below.